Evidence map›Paper›PMID 42550684›Full record

ArticleSTAR protocols2026

Protocol for in vitro chemoenzymatic synthesis of thiazole-containing macrocyclic peptides via ribosomal incorporation of thioamides.

Akihiro Saito, Yuki Goto

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Akihiro SaitoDepartment of Chemistry, Graduate School of Science, Kyoto University, Sakyo, Kyoto 606-8502, Japan. Electronic address: saito.akihiro.88r@st.kyoto-u.ac.jp.
Yuki GotoDepartment of Chemistry, Graduate School of Science, Kyoto University, Sakyo, Kyoto 606-8502, Japan; Toyota Riken Rising Fellow, Toyota Physical and Chemical Research Institute, Sakyo, Kyoto 606-8502, Japan. Electronic address: goto.yuki.4x@kyoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backbone thiazole moieties (Thz) are prevalent structural features in peptidic natural products and contribute to favorable physicochemical properties. Here, we describe a protocol for in vitro chemoenzymatic synthesis of artificial Thz-containing macrocyclic peptides compatible with mRNA display workflows. We provide steps for preparing amino(thio)acid substrates and flexizyme-mediated tRNA acylation. We then detail procedures for ribosomal incorporation of thioamide linkages, spontaneous thioether macrocyclization and concomitant backbone thiazoline (Thn) formation, and enzymatic dehydrogenation of Thn to Thz to afford Thz-containing macrocycles. For complete details on the use and execution of this protocol, please refer to Saito et al.

Indexed as

Biotechnology and bioengineeringChemistryProtein expression and purification

Identifiers

PMID42550684
PMCPMC13469953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.